Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Baxter
Express Scripts
Boehringer Ingelheim

Last Updated: September 28, 2022

Investigational Drug Information for SP-8203


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug SP-8203?

SP-8203 is an investigational drug.

There have been 3 clinical trials for SP-8203. The most recent clinical trial was a Phase 2 trial, which was initiated on March 18th 2019.

The most common disease conditions in clinical trials are Stroke, Ischemic Stroke, and Ischemia. The leading clinical trial sponsors are Shin Poong Pharmaceutical Co. Ltd. and [disabled in preview].

Recent Clinical Trials for SP-8203
TitleSponsorPhase
Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPAShin Poong Pharmaceutical Co. Ltd.Phase 2
Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPAShin Poong Pharmaceutical Co. Ltd.Phase 2
Safety, Tolerability and Pharmacokinetics of SP-8203Shin Poong Pharmaceutical Co. Ltd.Phase 1

See all SP-8203 clinical trials

Clinical Trial Summary for SP-8203

Top disease conditions for SP-8203
Top clinical trial sponsors for SP-8203

See all SP-8203 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Baxter
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.